| # | % | |||||
|---|---|---|---|---|---|---|
| 101 | CERUS CORP | 18,950 | 118,000 | 0.08% | ||
| 102 | REAL IND INC COM | 17,810 | 109,000 | 0.07% | ||
| 103 | I D SYSTEMS INC | 20,245 | 100,000 | 0.06% | ||
| 104 | OCULAR THERAPEUTIX INC | 12,275 | 84,000 | 0.05% | ||
| 105 | NOKIA CORP | 11,850 | 69,000 | 0.04% | ||
| 106 | ENZO BIOCHEM INC | 12,915 | 66,000 | 0.04% | ||
| 107 | CLIFFS NAT RES INC | 10,052 | 59,000 | 0.04% | ||
| 108 | PEREGRINE PHARMACEUTICALS IN | 15,000 | 6,000 | 0.00% | ||
| 109 | DYAX CORP COM CVR | 28,950 | 0 | 0.00% |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0001482611-16-000034, filed 2016.10.18).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
